Friedlander M
No ORCID on file
· 4 papers in corpus
· active 2009-2025
Top journals
Frequent coauthors
- Jonathan S. Berek 2
- Renz M 2
- Connolly JE 1
- Goss G 1
- Goh JC 1
- Heong V 1
- Kim HS 1
- Chay WY 1
- Kim JW 1
- Choi CH 1
2025
In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high-grade serous carcinomas (HGSCs)…
2021
In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high-grade serous carcinomas (HGSC).…
2020
BackgroundThe optimal treatment of recurrent ovarian clear cell carcinoma remains unknown. There is increasing rationale to support the role of immune checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1)/programmed dea…
2009
BackgroundBreast cancer is the most common cancer in women in developed countries, and 12% of breast cancer occurs in women 20-34 years. Survival from breast cancer has significantly improved, and the potential late effects of treatment and…